The hydroxyurea-induced loss of double-minute chromosomes containing amplified epidermal growth factor receptor genes reduces the tumorigenicity and growth of human glioblastoma multiforme

Neurosurgery
G W CanuteP J Hahn

Abstract

We investigated whether the hydroxyurea-induced loss of double-minute chromosomes containing amplified epidermal growth factor receptor (EGFR) genes would lead to a loss of tumorigenicity of a glioblastoma multiforme cell line. Glioblastoma multiforme cells were treated in vitro with 0 (HU0) or 100 micromol/L (HU100) hydroxyurea and then injected into the flanks of nude mice. Survival and tumor volumes were evaluated. Pulsed-field gel electrophoresis, Southern blot hybridization, and slot-blot analysis were used to determine EGFR amplification levels. Flow cytometry and immunofluorescent staining were used for cell-cycle analysis and EGFR protein expression. Prior to injection, HU100 cells lost 95% of their amplified EGFR genes and developed into tumors 6 weeks after injection versus 3 weeks for HU0 cells. Mice with HU100 tumors had a median survival of 62 days versus 43 days for control mice with HU0 tumors. Pulse-field gel electrophoresis analysis showed that HU100 tumors had reamplified the EGFR gene as double-minute chromosomes of the same size as those originally present before hydroxyurea treatment. When HU100 cells were cultured in the absence of hydroxyurea, the EGFR gene also reamplified. HU100 cells grew at less than ...Continue Reading

References

May 1, 1992·Mutation Research·G N Fuller, S H Bigner
Sep 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·D D Von HoffG M Wahl
Apr 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·A J WongB Vogelstein
Jan 1, 1992·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M ChaffanetA L Benabid
May 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·A J EkstrandV P Collins
Sep 1, 1990·Brain Pathology·S H Bigner, B Vogelstein
Aug 15, 1991·Biochemical and Biophysical Research Communications·P A HumphreyD D Bigner
Jan 1, 1990·Cancer Communications·W K YungM C Hung
Nov 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·N SugawaV P Collins
Dec 1, 1989·Journal of Neurosurgery·M S MahaleyB B Peace
Oct 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·A J WongB Vogelstein
Oct 1, 1994·Genes, Chromosomes & Cancer·J HeC D James
Apr 27, 1995·The New England Journal of Medicine·S CortelazzoT Barbui
Aug 2, 1994·Proceedings of the National Academy of Sciences of the United States of America·R NishikawaH J Huang
Jan 21, 1993·International Journal of Cancer. Journal International Du Cancer·O EngebraatenO D Laerum
Nov 1, 1995·Glia·A von DeimlingO D Wiestler

❮ Previous
Next ❯

Citations

Dec 5, 2014·Nature Communications·Sergey NikolaevStylianos E Antonarakis
Jun 5, 2001·Journal of Cellular Biochemistry. Supplement·T Kanda, G M Wahl
Feb 6, 2017·Genome Medicine·E Zeynep Erson-OmayMurat Günel
Dec 31, 1998·Current Opinion in Neurology·J L Darling, T J Warr
Jun 15, 2016·Biochemistry. Biokhimii︠a︡·O P Kisurina-EvgenievaG E Onishchenko
Sep 2, 1998·Genomics·R Rizwana, P J Hahn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.